Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.37
Delayed Data
As of Jan 20
 +0.09 / +2.74%
Today’s Change
2.51
Today|||52-Week Range
12.66
-8.42%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close3.28
Today’s open3.28
Day’s range3.28 - 3.41
Volume85,313
Average volume (3 months)414,274
Market cap$61.5M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-1.35%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.28-5.73%
NTECIntec Pharma Ltd+0.05+0.95%
AFMDAffimed NV-0.35-16.28%
EPIXESSA Pharma Inc0.000.00%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts


Search for Jobs